Peer-influenced content. Sources you trust. No registration required. This is HCN.
Renal & Urology News
This study challenges the conventional reliance on BCR as a primary end point in prostate cancer trials, emphasizing the need for a more comprehensive approach that includes overall survival rates.
Oncology, Medical September 11th 2023
Annals of Internal Medicine
This meta-analysis provides a comprehensive look at the factors affecting testosterone levels in men, highlighting the importance of considering age, lifestyle, and health conditions for accurate diagnosis.
Endocrinology, Diabetes, Metabolism September 7th 2023
Understanding the impact of lymphovascular invasion on overall survival in RCC patients is crucial for surgical decision-making and postoperative care.
Oncology, Medical September 5th 2023
New research reveals significant differences in overall survival rates based on the site of visceral metastases in metastatic prostate cancer. Discover how these insights could shape your approach to patient care.
Oncology, Radiation September 5th 2023
Discover how real-world data on 177Lu PSMA validates its efficacy in mCRPC treatment, providing actionable early markers for therapeutic response. Learn how these findings can enhance your clinical decision-making.
Oncology News Central (ONC)
Explore the nuanced implications of the FDA’s accelerated approval of enfortumab vedotin plus pembrolizumab for cisplatin-ineligible urothelial carcinoma patients, including questions on optimal treatment duration and adverse effects.
Oncology, Medical August 28th 2023